Interested in working for one of our startups? Several positions currently available

As our startups grows, they need new more talent to join their teams. At this moment, several portfolio companies are looking to appoint colleagues in senior positions. Are you, or anyone in your network, the one they are looking for?

TRINE: Head of Investments

We are looking for a senior leader to join us as Head of Investments at Trine. You will report directly to the CEO and you will be responsible for supporting the Investments Team towards high performance and for Trine’s growth across its entire portfolio. This is an opportunity to lead a high performing team at a pivotal time in Trine’s growth.

More information:

Gastrofy: Chairman of the Board

Gastrofy AB develops shopping technology that drive top line growth for our FMCG-partners. The grocery industry is in a rapid shift, from offline to online, with a race for market share as a result. Gastrofy has a unique position by having developed the worlds best logic for converting recipes to products. Used by retailers on their own domains, and on all sites with food inspiration, the company control the transaction through a commission based business model.

Link to job posting: Download here

Contact: Robin Rendahl, +46 73-940 30 62

Winningtemp: Chairman of the Board

Winningtemp is a revolutionary technology developed to create prosperous and healthy workplaces. The company of the same name was founded in Sweden in 2014 by Mathias Hansson Fredlund och Pierre Lindmark, combining their comprehensive experience and expertise within IT and human resources respectively.

Link to job posting: Download here
Contact: Andreas Höye,

Astatine: Project Leader / Business Developer

Chalmers Ventures currently has a very exciting offer for a person who wishes to be responsible for commercializing a project which can make a great difference within cancer treatment. Radiotherapy methods are seen by many as the next step within cancer therapy, which is done by connecting a radioactive nuclide to an antibody or carrier molecule specific to a certain tumor type. This treatment has very high specificity, fewer side effects and can also identify unknown metastases. This project enables use of astatine (At-211), one of the most promising alpha radiating particles for internal radiation of cancer tumors. The project is close to market and there is a possibility to become co-founder of a future company.

Link to job posting: Download here
Contact: Mattias Münnich, & Evelina Wängberg,